In 2019, there were new drugs approved by the FDA to help in the treatment of SCD like Crizanlizumab and Voxelotor aka Oxbryta which was the first treatment aimed at targeting the root cause of sickle cell.
Related: 5 DRUGS FOR SC TREATMENT TO ASK YOUR DOCTOR ABOUT
There was also a study published last year by a team of Brazilian researchers that revealed that low levels of SELENIUM in people with sickle cell disease were linked to red blood cells damage and destruction. Selenium is a nutrient that plays an important role in the body's defense system against oxidative stress. It was reported that eating more selenium rich foods like seafood, cereals and dairy products may help those with sickle cell disease improve their overall health
I tried to update you as much as possible last year on any new developments in regards to treatments, investigational therapies and societal focus on those living with the disease. In 2020, I hope to continue to do the same and the future of SCD is still to eliminate the barriers to care that continue to affect patients. Using strategies like telehealth, telemedicine and telemonitoring to improve access to evidence-based SCD care and increasing access to insurance for all sickle cell patients are just some of the ways to improve the disease's overall care approach.
Sickle cell patients deserve a system that can evolve with their changing needs and so continued access to comprehensive care is also a key focus for the future of SCD. With an ever increasing population of African Americans with this disease, it is imperative that a more aggressive and urgent race free lens is employed in the care and treatment given to those affected within this community.
I hope to keep bringing you any new updates regarding SC care as I come across them and I hope that whatever information I provide here is helpful in some way. The future looks promising for sickle cell because all hands are on deck to find more effective treatments and alternative cures.
Always Love 💓
ibogirl
No comments:
Post a Comment